The Phase II trial, designed by researchers at SickKids will examine a combination cannabinoid therapy for children with Dravet Syndrome, a rare and …
The Phase II trial, designed by researchers at SickKids will examine a combination cannabinoid therapy for children with Dravet Syndrome, a rare and …